CNMD
Conmed Corp.

213
Mkt Cap
$1.31B
Volume
520,842.00
52W High
$74.70
52W Low
$38.32
PE Ratio
19.61
CNMD Fundamentals
Price
$40.39
Prev Close
$39.80
Open
$39.94
50D MA
$43.59
Beta
0.94
Avg. Volume
555,641.63
EPS (Annual)
$4.25
P/B
1.24
Rev/Employee
$334,033.33
Loading...
Loading...
News
all
press releases
Here's Why Conmed (CNMD) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks·4d ago
News Placeholder
More News
News Placeholder
CONMED Corporation (NYSE:CNMD) Receives Average Rating of "Hold" from Analysts
CONMED Corporation (NYSE:CNMD - Get Free Report) has received a consensus rating of "Hold" from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. One research...
MarketBeat·6d ago
News Placeholder
Oversold Conditions For CONMED (CNMD)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·9d ago
News Placeholder
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio
CNMD is set to exit its gastroenterology portfolio to streamline its focus on higher-growth surgical platforms and boost long-term margins.
Zacks·11d ago
News Placeholder
CONMED (NYSE:CNMD) Price Target Lowered to $52.00 at Bank of America
Bank of America dropped their target price on shares of CONMED from $65.00 to $52.00 and set a "neutral" rating on the stock in a report on Monday...
MarketBeat·11d ago
News Placeholder
CONMED (NYSE:CNMD) Trading Down 6.7% - Should You Sell?
CONMED (NYSE:CNMD) Stock Price Down 6.7% - Here's What Happened...
MarketBeat·13d ago
News Placeholder
CONMED (NYSE:CNMD) Hits New 52-Week Low - What's Next?
CONMED (NYSE:CNMD) Reaches New 52-Week Low - Here's What Happened...
MarketBeat·13d ago
News Placeholder
Why Is Conmed (CNMD) Up 0.1% Since Last Earnings Report?
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·14d ago
News Placeholder
CONMED Corporation Announces Strategic Exit from Gastroenterology Product Lines
CONMED Corporation (NYSE: CNMD) today announced its intention to exit its gastroenterology product lines as part of its broader portfolio optimization strategy. This exit allows CONMED to fully align...
Business Wire·14d ago
News Placeholder
Zacks.com featured highlights include Plains GP, Edison International, TD SYNNEX, CONMED and PG&E
Plains GP, Edison International, TD SYNNEX, CONMED and PG&E stand out for value as low EV-to-EBITDA ratios spotlight potential opportunities.
Zacks·14d ago
<
1
2
...
>

Latest CNMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.